Ets-1 regulates its target genes mainly by DNA methylation in human ovarian cancer

被引:7
作者
Wan, S. -M. [1 ]
Peng, P. [1 ]
Guan, T. [1 ]
机构
[1] Gen Hosp, Dept Gynecol, PLA, Guangzhou Mil Command, Guangzhou 510010, Guangdong, Peoples R China
关键词
DNA methylation; Ets-1; gene expression profile; ovarian cancer; TRANSCRIPTION FACTOR ETS-1; MESSENGER-RNA EXPRESSION; BREAST-CANCER; GROWTH-FACTOR; MARKER; ANGIOGENESIS; SURVIVAL; MMP-1;
D O I
10.3109/01443615.2013.820268
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Ovarian cancer is the second most common gynaecological cancer worldwide, and its molecular mechanism has not been completely understood. Ets-1 is a member of the Ets transcription family and can play important roles in the regulation of extracellular matrix remodelling, invasion, angiogenesis and drug resistance in several malignancies, including ovarian cancer. In the current study, we downloaded two datasets from Gene Expression Omnibus database and sought to explore the regulation mechanism of Ets-1 in ovarian cancer by computational analysis of gene expression profiles. Microarray analysis identified a total of 548 genes that were regulated by Ets-1 in ovarian cancer. Functional annotation of these genes revealed that Ets-1 may be involved in several biological processes, both physiological and pathological, such as system development, response to stimulus, vascular endothelial growth factor (VEGF) production, morphogenesis, cell proliferation, cell adhesion and signal transduction. Further, DNA methylation analysis of the DEGs found that 26.5% (145) of them were differentially methylated genes in ovarian cancer. Our results provide insight into the mechanism of Ets-1 regulating the transcription of its target genes in the complex and multistep process of ovarian cancer progression.
引用
收藏
页码:877 / 881
页数:5
相关论文
共 32 条
  • [1] Gene Ontology: tool for the unification of biology
    Ashburner, M
    Ball, CA
    Blake, JA
    Botstein, D
    Butler, H
    Cherry, JM
    Davis, AP
    Dolinski, K
    Dwight, SS
    Eppig, JT
    Harris, MA
    Hill, DP
    Issel-Tarver, L
    Kasarskis, A
    Lewis, S
    Matese, JC
    Richardson, JE
    Ringwald, M
    Rubin, GM
    Sherlock, G
    [J]. NATURE GENETICS, 2000, 25 (01) : 25 - 29
  • [2] NCBI GEO: mining tens of millions of expression profiles - database and tools update
    Barrett, Tanya
    Troup, Dennis B.
    Wilhite, Stephen E.
    Ledoux, Pierre
    Rudnev, Dmitry
    Evangelista, Carlos
    Kim, Irene F.
    Soboleva, Alexandra
    Tomashevsky, Maxim
    Edgar, Ron
    [J]. NUCLEIC ACIDS RESEARCH, 2007, 35 : D760 - D765
  • [3] Behrens P, 2001, INT J MOL MED, V8, P149
  • [4] Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial-mesenchymal transition in ovarian carcinomas
    Colomiere, M.
    Ward, A. C.
    Riley, C.
    Trenerry, M. K.
    Cameron-Smith, D.
    Findlay, J.
    Ackland, L.
    Ahmed, N.
    [J]. BRITISH JOURNAL OF CANCER, 2009, 100 (01) : 134 - 144
  • [5] Ets1 is an effector of the transforming growth factor β (TGF-β) signaling pathway and an antagonist of the profibrotic effects of TGF-β
    Czuwara-Ladykowska, J
    Sementchenko, VI
    Watson, DK
    Trojanowska, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (23) : 20399 - 20408
  • [6] Ets-1 mRNA expression in effusions of serous ovarian carcinoma patients is a marker of poor outcome
    Davidson, B
    Risberg, B
    Goldberg, I
    Nesland, JM
    Berner, A
    Tropé, CG
    Kristensen, GB
    Bryne, M
    Reich, R
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (12) : 1493 - 1500
  • [7] Davidson B, 2001, CLIN CANCER RES, V7, P551
  • [8] Ets transcription factors and human disease
    Dittmer, J
    Nordheim, A
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1998, 1377 (02): : F1 - F11
  • [9] Using GOstats to test gene lists for GO term association
    Falcon, S.
    Gentleman, R.
    [J]. BIOINFORMATICS, 2007, 23 (02) : 257 - 258
  • [10] Clinical implications of expression of ETS-1 related to angiogenesis in uterine cervical cancers
    Fujimoto, J
    Aoki, I
    Toyoki, H
    Khatun, S
    Tamaya, T
    [J]. ANNALS OF ONCOLOGY, 2002, 13 (10) : 1598 - 1604